Marrow Suppression News Today

Press release content from Business Wire. The AP news staff was not involved in its creation. Bayer to Present New Clinical Data in Indolent non-Hodgkin’s Lymphoma and Additional Research on its Oncology Portfolio at AACR Annual Meeting 2021 April 6, 2021 GMT WHIPPANY, N.J.--(BUSINESS WIRE)--Apr 6, 2021-- Bayer will present new research across its oncology portfolio at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, taking place over two weeks on April 10-15 a...

Search jobs 08-Feb-2021 New data presented from NUBEQA ® (darolutamide) and Xofigo ® (radium Ra 223 dichloride) studies demonstrate Bayer’s continued commitment to ongoing prostate cancer research across different stages of the disease Abstracts: 240, 239, 217, TPS266, 105, 135, TPS182, 48, 98, TPS175, 136 WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer announced today that new NUBEQA ® (darolutamide) and Xofigo ® (radium Ra 223 dichloride) data will be presented at the 2021 A...